Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs
Abstract Background Hepatitis C virus (HCV) infection is increasingly prevalent among people who inject drugs (PWID) in the context of the current US opioid crisis. Although curative therapy is available and recommended as a public health strategy, few PWID have been treated. We explore PWID narrati...
Main Authors: | Ellen Childs, Sabrina A. Assoumou, Katie B. Biello, Dea L. Biancarelli, Mari-Lynn Drainoni, Alberto Edeza, Peter Salhaney, Matthew J. Mimiaga, Angela R. Bazzi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | Harm Reduction Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12954-019-0286-6 |
Similar Items
-
“We don't get much of a voice about anything”: perspectives on photovoice among people who inject drugs
by: Mari-Lynn Drainoni, et al.
Published: (2019-11-01) -
Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs
by: K. B. Biello, et al.
Published: (2018-11-01) -
Profile of drug users in the residential treatment centers of Tehran, Iran
by: Hossein Akbari, et al.
Published: (2019-08-01) -
Study protocol for an efficacy trial of the “PrEP for Health” intervention to increase HIV PrEP use among people who inject drugs
by: Angela R. Bazzi, et al.
Published: (2023-03-01) -
HCV prevalence and predominant genotype in IV drug users
by: Asad Andalibalshohada, et al.
Published: (2014-10-01)